SARM1 antibody (C-Term)
Quick Overview for SARM1 antibody (C-Term) (ABIN7466589)
Target
See all SARM1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- C-Term
-
Specificity
- Knockdown/Knockout validation was supported by references (PMID:36055989)
-
Cross-Reactivity
- Drosophila melanogaster, Human, Mouse
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein encompassing a sequence within the C-terminus region of human SARM1. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Validation: KO/KD, Orthogonal
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.4 mg/mL
-
Buffer
- 1XPBS pH 7, 1 % BSA, 20 % Glycerol, 0.025 % ProClin 300
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- SARM1 (Sterile alpha and TIR Motif Containing 1 (SARM1))
-
Alternative Name
- sterile alpha and TIR motif containing 1
-
Background
- Sterile alpha and TIR motif containing 1 , MyD88-5 , SAMD2 , SARM,Involved in innate immnune response. Acts as a negative regulator of TICAM1/TRIF-dependent Toll-like receptor signaling by inhibiting induction of TLR3- and TLR4-dependent genes. Specifically blocks TICAM1/TRIF-dependent transcription-factor activation and gene induction, without affecting the MYD88-dependent pathway or non-TLR signaling. Negative regulator of NF-kappa-B and IRF activation.
-
Molecular Weight
- 79 kDa
-
Gene ID
- 23098
-
UniProt
- Q6SZW1
-
Pathways
- TLR Signaling, Activation of Innate immune Response, Toll-Like Receptors Cascades
Target
-